Navigation Links
Genetic-Key to Stop Heroin Addicts

Researchers from University of Adelaide in the Discipline of Pharmacology have found a genetic key for improving treatment success rates of heroin addicts around// the world. They have discovered a gene that helps determining the optimum methadone dosage levels for heroin addicts.

The study reveals why people are either less efficient or more effective in distributing drugs throughout their body to the central nervous system. It will allow people undergoing methadone treatment programs to be tested for the genetic variation to determine optimal treatment doses. The study results were published in journal Clinical Pharmacology and Therapeutics.

When the heroin addicts were tested, it was found that 25% of the people with a mutation of the gene can cope on lower doses of methadone. But the majority without the mutation process faster methadone, need almost double the amount to stave off heroin withdrawal.

It was also found that about 62% of drug addicts dropped out of methadone programs because of severe withdrawal symptoms.

Lead researcher and pharmacologist, Dr Janet Coller said "Individualised dosing may decrease the incidence of withdrawal symptoms in some people and therefore encourage them to continue with the methadone treatment" and added that “Accurate determination of methadone doses was essential to successfully treat users.”

This research is the first of its kind to investigate the problem of inaccurate dosing, which sees almost two out of every three of Australia's methadone users drop out of programs prematurely. Most fail in the first four weeks of the treatment, when the withdrawal effects are most severe. "It's entirely possible that the people who are failing are doing so because their genotype is such that they need more methadone than they're getting," says Dr Janet Coller. Dr Coller and her team tested 60 heroin addicts for the gene, called abcb1, and worked out whether they were getting the r
'"/>




Page: 1 2

Related medicine news :

1. Heroin to Treat Addiction
2. General Anesthesia For Heroin Detoxification Is No Good
3. Heroin Addicts Chained For Cure
4. Heroin Use May Reduce In Zurish, Study Says
5. Seizure of Low Quantity of Heroin is No Ground for Bail: HC
6. Heroin, Killed 130 People In US
7. Naloxone Prevents Heroin Overdose
8. Afghanistans double-edged problem - AIDS and Heroin
9. Prescription Opioids Abused More Than Heroin - A Report Says
10. Opioid Abuse More Prevalent than Heroin
11. Painkiller Dihydrocodeine May Replace Methodone In Treating Heroin Addicts
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Genetic Key Stop Heroin Addicts

(Date:5/22/2013)... 21 May 2013, Paris, France: Results from ... 2013 today question whether bivalirudin is superior ... blockade, showing similar 30-day mortality in patients ... (NSTE-ACS) undergoing percutaneous coronary intervention (PCI)., European ... alone as an alternative to unfractionated heparin ...
(Date:5/22/2013)... 2013 In the past decade, ... and courts with donated uniforms, shoes, balls and ... dedicated to partnering with manufacturers to provide youth with ... of $8.8 million in sports and fitness equipment over ... kids outfitted for physical activity. , An inaugural ...
(Date:5/22/2013)... Following the success of last year’s 1,000 ... Body Boot Camp Kincardine has announced it will be ... on June 3rd at its Kincardine fitness center ... Ontario.     , Fit Body Boot Camp’s 1,000 lb. Meltdown ... residents to lose a total of 1,000 pounds in ...
(Date:5/22/2013)... NJ (PRWEB) May 22, 2013 ... and management solutions for social enterprise collaboration platforms, ... a consulting firm based in Chicago, Ill. The ... their products and provide best-in-class solutions for SharePoint ... improve collaboration. , AvePoint’s DocAve Software Platform ...
(Date:5/22/2013)... 2013 Poor adherence to appropriate medication ... medical complications and death (some 125,000 deaths in the ... increased health-care costs. It’s been estimated that between 33% ... to poor medication adherence — a reality that costs ... Indeed, so dire is the degree of medication non-adherence ...
Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
... PHILADELPHIA, Nov. 13 Lippincott Williams & Wilkins (LWW) ... Nurses Association (HPNA) has appointed Betty Ferrell, PhD, MA, ... of Hospice & Palliative Nursing. LWW is part of ... business intelligence for students, professionals, and institutions in medicine, ...
... to Create 1,500 Jobs , HERSHEY, Pa., Nov. 13 ... on the new Penn State Hershey Children,s Hospital and said ... economy, but most importantly, for sick children and their families. ... and another 1,200 jobs once the facility is completed. , ...
... to absorb potent antioxidant , FRIDAY, Nov. 13 (HealthDay ... of the yellow curry ingredient curcumin, which is being ... cancer, psoriasis and Alzheimer,s disease. , Curcumin, the active ... However, digestive juices in the gastrointestinal tract quickly destroy ...
... Md., Nov. 13 Several weeks ago, the FDA announced ... the post-harvest processing of raw Gulf Coast oysters harvested in ... policy, which would affect about 25% of the total annual ... who suffer severe and painful illness and death from the ...
... Calif., Nov. 13 Human Pheromone Sciences, Inc. (OTC Bulletin ... the three and nine month periods ended September 30, 2009. ... of $273,000 represented a 4% increase from the revenues of ... income of $10,000 ($0.00 per share) as compared with a ...
... ROCHESTER, Minn., Nov. 13 Here are highlights from the ... may cite this publication as often as you wish. Reprinting ... Letter attribution is required. Include the ... www.HealthLetter.MayoClinic.com ...
Cached Medicine News:Health News:Journal of Hospice & Palliative Nursing Names New Editor 2Health News:Journal of Hospice & Palliative Nursing Names New Editor 3Health News:Governor Rendell Helps to Break Ground for New Children's Hospital at Penn State Hershey 2Health News:FDA Statement on Vibrio Vulnificus in Raw Oysters 2Health News:FDA Statement on Vibrio Vulnificus in Raw Oysters 3Health News:Human Pheromone Sciences Announces Third Quarter Results 2Health News:Human Pheromone Sciences Announces Third Quarter Results 3Health News:Human Pheromone Sciences Announces Third Quarter Results 4Health News:November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments 2Health News:November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments 3Health News:November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments 4Health News:November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments 5
(Date:5/22/2013)... May 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition ... Guidebook Series (4) 2013 Edition Material and Clinical ... Drug Registration: A Guidebook of Registration Application for ... to its online database. The traditional ... are always regarded by occidental as mysterious medicines. ...
(Date:5/22/2013)... VANCOUVER, British Columbia , May 22, 2013  OncoGenex ... the development of novel therapeutics to target mechanisms of treatment ... investigational compounds, custirsen and OGX-427, will be presented as "Trials ... of the American Society of Clinical Oncology (ASCO) in ... 4. Despite the availability of drugs that ...
(Date:5/21/2013)... 2013 Concord Medical Services Holdings Limited ("Concord ... a leading specialty hospital management solution provider and operator ... centers in China and the parent of Chang,an Hospital, ... first quarter ended March 31, 2013 [1] . ... revenue, which consists of net revenues generated from the ...
Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5Concord Medical Reports First Quarter 2013 Financial Results 2Concord Medical Reports First Quarter 2013 Financial Results 3Concord Medical Reports First Quarter 2013 Financial Results 4Concord Medical Reports First Quarter 2013 Financial Results 5Concord Medical Reports First Quarter 2013 Financial Results 6Concord Medical Reports First Quarter 2013 Financial Results 7Concord Medical Reports First Quarter 2013 Financial Results 8Concord Medical Reports First Quarter 2013 Financial Results 9Concord Medical Reports First Quarter 2013 Financial Results 10Concord Medical Reports First Quarter 2013 Financial Results 11Concord Medical Reports First Quarter 2013 Financial Results 12Concord Medical Reports First Quarter 2013 Financial Results 13
... 28, 2011 Pharmasset, Inc. (Nasdaq: VRUS ) ... Conference being held May 2 to 4, 2011 at the ... Merrill Lynch Healthcare Conference being held May 10 to 12, ... Price, Pharmasset,s President and Chief Executive Officer, will provide an ...
... 28, 2011 The U.S. Food and Drug ... with prednisone (a steroid) to treat patients with ... prior docetaxel (chemotherapy). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... sex hormone testosterone stimulates prostate tumors to grow. ...
Cached Medicine Technology:Pharmasset to Present at Two Upcoming Investor Conferences 2Pharmasset to Present at Two Upcoming Investor Conferences 3FDA Approves Zytiga for Late-Stage Prostate Cancer 2FDA Approves Zytiga for Late-Stage Prostate Cancer 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: